Preclinical Imaging Market Size to Reach USD 7.24 Billion by 2035 as Pharmaceutical R&D and Drug Discovery Investments Accelerate – SNS Insider
Summary
The preclinical imaging market is projected to grow from USD 4.58 billion in 2025 to USD 7.24 billion by 2035. Pharma and biotech companies are increasing R&D spending and adopting imaging biomarkers to improve drug discovery and development workflows. The report highlights strong demand from pharmaceutical firms, biotechnology organizations, CROs, universities, and research institutes. It also notes product updates from Bruker and Revvity that expand imaging capabilities for advanced research. North America leads the market today, while Asia-Pacific is expected to grow the fastest over the forecast period.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected